One study suggests these drugs could increase depression risk in heart attack survivors who retained normal heart pumping ...

In obesity, we are advancing WVE-007 ... poor tolerability and high discontinuation rates. At Research Day, we shared ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a ...

Director gets a hilarious storyline suggestion for it and you are going to love it On This Day At The Box Office: Revisiting Son Of Sardaar on its 12th anniversary ‘Is This A Hard Launch?’ Fans ...

Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress hormone norepinephrine, according to a new study.

People with obesity and high blood pressure got the best results ... Two doses were examined: 600 IU/day (the Institutes of ...

Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine's (IOM) recommended daily dose does not provide additional health benefits, ...

But obesity in women increased from 10% to 25%, and in men from 17% to 27%. In the US, the purchase of sugar fell by 37g a ...

The global rise in obesity, a major risk factor for chronic illnesses and early mortality, has brought attention to the role ...

FDA approved the Varipulse pulsed field ablation (PFA) platform for drug refractory paroxysmal atrial fibrillation, Johnson & ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Two-thirds of the UK population are either overweight or obese - a crisis that costs billions each year in healthcare and lost productivity. Yet ...